GLP1R and metabolic syndrome: For example, intestinal microbiota dysbiosis disrupts normal GLP-1 signaling (252), reduced GLP-1 production is associated with metabolic syndrome (insulin resistance) (253), and reduced GLP-1 is associated with reduced BDNF in the brain (254).